Optimizing broad-spectrum treatment: The role of ceftazidime-avibactam in managing Gram-negative bloodstream infections
At a recent Pfizer-sponsored webinar, Dr Lee Tau Hong, Infectious Disease Specialist from Singapore, provided insights into the local epidemiology of bloodstream infections across Singapore, Malaysia, and the Philippines. Joining him, Professor Souha Kanj from the American University of Beirut Medical Center, Lebanon, emphasized the critical impact of the timely use of broad-spectrum antibiotic in treating bloodstream infections. She further explored the role of ceftazidime-avibactam in addressing multidrug-resistant Gram-negative bloodstream infections, highlighting its potential to improve patient outcomes.
